Evidence map›Paper›PMID 36881645›Full record

ArticleEmerging microbes & infections2023

Emerging triple-reassortant influenza C virus with household-associated infection during an influenza A(H3N2) outbreak, China, 2022.

Lan Cao, Ying Lu, Chaojun Xie, Yiyun Chen, Lijun Liang, Tengfei Zhou, Ziyi Zeng, Chen Wen, Biao Di, Baisheng Li and 2 more

Open access · goldFull text readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Lan CaoInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Ying LuInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Chaojun XieHuadu District Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Yiyun ChenInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Lijun LiangGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Tengfei ZhouInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Ziyi ZengHuadu District Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Chen WenHuadu District Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Biao DiInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Baisheng LiGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Kuibiao LiInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Zhoubin ZhangInstitute of Public Health, Guangzhou Medical University and Guangzhou Center for Disease Control and Prevention, Guangzhou, People's Republic of China.
Guangzhou Center for Disease Control and Prevention · CNCenter for Disease Control · TWGuangzhou Medical University · CNGuangdong Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent research have shown that influenza C virus (ICV) has a possible higher clinical impact than previously thought. But knowledge about ICV is limited compared with influenza A and B viruses, due to poor systematic surveillance and inability to propagate. Herein, a case infected with triple reassortant ICV was identified during an influenza A(H3N2) outbreak, which was the first report of ICV infection in mainland China. Phylogenetic analysis showed that this ICV was triple reassortant. Serological evidence revealed that the index case might be related to family-clustering infection. Therefore, it is essential to heighten surveillance for the prevalence and variation of ICV in China, during the COVID-19 pandemic.

Indexed as

COVID-19GammainfluenzavirusInfluenza, HumanChinaDisease OutbreaksHumansInfluenza A Virus, H3N2 SubtypePandemicsPhylogenyChinafamily clusteringinfectionInfluenza C virustriple reassortant

Identifiers

PMID36881645
PMCPMC10013421
OpenAlexW4323352355

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.